News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,160 Results
Type
Article (13863)
Company Profile (294)
Press Release (246003)
Section
Business (79321)
Career Advice (148)
Deals (13179)
Drug Delivery (32)
Drug Development (50282)
Employer Resources (31)
FDA (5669)
Job Trends (5111)
News (144054)
Policy (10013)
Tag
Academia (901)
Alliances (21466)
Alzheimer's disease (734)
Approvals (5643)
Artificial intelligence (62)
Bankruptcy (97)
Best Places to Work (4496)
Biotechnology (242)
Breast cancer (65)
Cancer (686)
Cardiovascular disease (62)
Career advice (129)
CAR-T (55)
Cell therapy (174)
Clinical research (39783)
Collaboration (233)
Compensation (96)
COVID-19 (1002)
C-suite (66)
Cystic fibrosis (66)
Data (783)
Diabetes (73)
Diagnostics (1199)
Earnings (28972)
Events (46820)
Executive appointments (185)
FDA (5954)
Funding (239)
Gene editing (55)
Gene therapy (145)
GLP-1 (299)
Government (1063)
Healthcare (6531)
Infectious disease (1036)
Inflammatory bowel disease (94)
IPO (7175)
Job creations (859)
Job search strategy (125)
Layoffs (184)
Legal (1373)
Lung cancer (110)
Manufacturing (74)
Medical device (2553)
Medtech (2554)
Mergers & acquisitions (6099)
Metabolic disorders (222)
Neuroscience (938)
NextGen Class of 2024 (1998)
Non-profit (843)
Northern California (940)
Obesity (122)
Opinion (91)
Parkinson's disease (60)
Patents (51)
People (24959)
Pharmaceutical (49)
Phase I (13991)
Phase II (18503)
Phase III (11731)
Pipeline (318)
Postmarket research (846)
Preclinical (5920)
Radiopharmaceuticals (204)
Rare diseases (167)
Real estate (1409)
Regulatory (8200)
Research institute (930)
Southern California (857)
Startups (1963)
United States (7528)
Vaccines (159)
Weight loss (76)
Date
Today (93)
Last 7 days (589)
Last 30 days (2283)
Last 365 days (20687)
2024 (18885)
2023 (22412)
2022 (26822)
2021 (27807)
2020 (23358)
2019 (16224)
2018 (11739)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16822)
Australia (2836)
California (2125)
Canada (704)
China (159)
Colorado (79)
Connecticut (84)
Europe (36226)
Florida (222)
Georgia (62)
Illinois (125)
Indiana (54)
Kansas (55)
Maryland (298)
Massachusetts (1685)
Michigan (48)
Minnesota (93)
New Jersey (539)
New York (603)
North Carolina (398)
Northern California (940)
Ohio (78)
Pennsylvania (424)
South America (207)
Southern California (857)
Texas (222)
Washington State (216)
260,160 Results for "3dbio therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial
3DBio Therapeutics, a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant.
June 2, 2022
·
8 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
3DBio Therapeutics, Inc. Strengthens Board of Directors, Welcomes Scott Dylla, Ph.D.
3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced Scott Dylla, Ph.D has joined its Board of Directors.
October 30, 2020
·
2 min read
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Pharm Country
3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced it has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear in patients with microtia
November 19, 2019
·
2 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization
Following two layoffs in less than three months, Viracta Therapeutics may have around 18 employees left to advance its efforts to bring lead product candidate nana-val to market.
November 7, 2024
·
2 min read
·
Angela Gabriel
Pharm Country
3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear in patients with microtia.
December 6, 2019
·
3 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration
November 6, 2024
·
9 min read
1 of 26,016
Next
